Abstract
: To study early and late effect of intravitreal injection Ranibizumab on Cystoid Macular Edema(CME) because of Branch Retinal Vein Occlusion (BRVO). This Study included 25 Patients (age group≥18 year) with cystoid macular edema because of branch retinal vein occlusion attending to department of ophthalmology Nehru Chikitsalaya, B.R.D. Medical college, Gorakhpur.An observational study has been concluded in which early and late effect of intravitreal injection Ranibizumab on cystoid macular edema because of branch retinal vein occlusion. The mean age group being 58.53 year of total 25 patients with 13 male and 12 female patients with no dropout throughout the study. In 1 month of post injecton observation, 10 (40%) patients who presented within 1 month of onset of BRVO showed more gain in visual acuity and more reduction in central macular thickness (CMT) as compare to 15 (60%) patients who presented after 1 month of onset of BRVO.: Intravitreal Ranibizumab is more effective in patients presented early than late in improving best corrected visual acuity ( BCVA) and decreasing CMT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Clinical and Experimental Ophthalmology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
